NCT01345019 2022-11-08Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple MyelomaAmgenPhase 3 Completed1,718 enrolled 22 charts
NCT00896454 2018-10-17Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumAmgenPhase 2 Completed33 enrolled 22 charts
NCT00950911 2014-02-11Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyAmgenPhase 3 Completed35 enrolled 8 charts